RT Journal Article
SR Electronic
T1 Predicted failure of common Mpox PCR testing on a recent DRC clade I variant: Persistent genomic surveillance is critically important for accurate diagnostics
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.07.22.24310820
DO 10.1101/2024.07.22.24310820
A1 Gratalo, Dawn
A1 Morley, Valerie J.
A1 Oppenheim, Ben
A1 Philipson, Casandra W.
A1 Rush, Sarah
A1 Sureka, Swati
A1 Wolfe, Mitchell I.
A1 Simen, Birgitte B.
YR 2024
UL http://medrxiv.org/content/early/2024/07/23/2024.07.22.24310820.abstract
AB Pathogens can rapidly evolve to evade detection via existing diagnostic testing capabilities, creating blind spots for health care and security systems. Persistent genomic surveillance of pathogens can help identify and address these gaps. Here, we present a case study of a new lineage of Monkeypox virus Clade I that emerged during an outbreak in the Democratic Republic of the Congo, in which a genomic deletion allowed the virus to evade detection by current diagnostic assays. We rapidly developed and validated an updated assay. Availability of pathogen genomic data is a critical input, and often a bottleneck, to response efforts.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was funded by Ginkgo BioworksAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors